Endocannabinoid System: Chemical Characteristics and Biological Activity
Pharmaceuticals · 19.01.2023 · 16 (2) · 148
DOI: 10.3390/ph16020148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 19.01.2023. Verfasst von Bismarck Rezende und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Psychobiology, Roberto Alcântara Gomes Institute Biology (IBRAG), Rio de Janeiro State University (UERJ), Rio de Janei…. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro FAPERJ.
Abstract (Originalsprache)
The endocannabinoid system (eCB) has been studied to identify the molecular structures present in Cannabis sativa. eCB consists of cannabinoid receptors, endogenous ligands, and the associated enzymatic apparatus responsible for maintaining energy homeostasis and cognitive processes. Several physiological effects of cannabinoids are exerted through interactions with various receptors, such as CB1 and CB2 receptors, vanilloid receptors, and the recently discovered G-protein-coupled receptors (GPR55, GPR3, GPR6, GPR12, and GPR19). Anandamide (AEA) and 2-arachidoylglycerol (2-AG), two small lipids derived from arachidonic acid, showed high-affinity binding to both CB1 and CB2 receptors. eCB plays a critical role in chronic pain and mood disorders and has been extensively studied because of its wide therapeutic potential and because it is a promising target for the development of new drugs. Phytocannabinoids and synthetic cannabinoids have shown varied affinities for eCB and are relevant to the treatment of several neurological diseases. This review provides a description of eCB components and discusses how phytocannabinoids and other exogenous compounds may regulate the eCB balance. Furthermore, we show the hypo- or hyperfunctionality of eCB in the body and how eCB is related to chronic pain and mood disorders, even with integrative and complementary health practices (ICHP) harmonizing the eCB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Psychobiology, Roberto Alcântara Gomes Institute Biology (IBRAG), Rio de Janeiro State University (UERJ), Rio de Janeiro 20551-030, Brazil.
- Department of Biomedical Engineering, Tulane University, New Orleans, LA 70118, USA.
ORCID-Profile: Bismarck Rezende, Allan Kardec Nogueira Alencar, Fabrícia Lima Fontes-Dantas, Guilherme Carneiro Montes
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro FAPERJ
Zitieren
APA
Rezende, B., Alencar, A. K. N., de Bem, G. F., Fontes-Dantas, F. L., & Montes, G. C. (2023). Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals, 16(2), 148. https://doi.org/10.3390/ph16020148
Vancouver
Rezende B, Alencar AKN, de Bem GF, Fontes-Dantas FL, Montes GC. Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals. 2023;16(2):148. doi:10.3390/ph16020148
BibTeX
@article{Rezende2023,
author = {Rezende, Bismarck and Alencar, Allan Kardec Nogueira and de Bem, Graziele Freitas and Fontes-Dantas, Fabrícia Lima and Montes, Guilherme Carneiro},
title = {Endocannabinoid System: Chemical Characteristics and Biological Activity},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {2},
pages = {148},
doi = {10.3390/ph16020148}
}
EUVIMED